Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Κατάταξη σε μετοχές #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Τιμή μετοχής
$0.05124204
Κεφαλαιοποίηση
$7.78M
Αλλαγή (1 ημέρα)
0.51%
Αλλαγή (1 έτος)
-23.73%
Χώρα
CH
Εμπόριο Addex Therapeutics Ltd (ADXN)

Κατηγορία

Ιστορικό τιμής μετοχής για την Addex Therapeutics Ltd (ADXN)
Υψηλότερη τιμή κλεισίματος: $0.05 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $54.79 στις 2007-05-01
Ιστορικό τιμής μετοχής της Addex Therapeutics Ltd από 2007 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -6.77%
2025 5.69%
2024 28.65%
2023 -59.04%
2022 -89.21%
2021 -42.01%
2020 15.05%
2019 -25.63%
2018 1.94%
2017 22.36%
2016 -37.32%
2015 15.45%
2014 -35.66%
2013 -62.43%
2012 68.65%
2011 -41.91%
2010 -59.41%
2009 -21.49%
2008 -3.22%
2007 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$733.26 6.70%
CH
$1.07K -6.40%
KR
$255.97 13.59%
BE